China SXT Pharmaceuticals, Inc. (SXTC) Revenue 2017–2026
China SXT Pharmaceuticals, Inc. (SXTC) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$1.1MFY2026 · since FY2017: $4.9M → $1.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $1.1M | -34.6% |
| FY2025 | $1.7M | -9.7% |
| FY2024 | $1.9M | -2.2% |
| FY2023 | $2.0M | -24.2% |
| FY2022 | $2.6M | -45.5% |
| FY2021 | $4.8M | -7.5% |
| FY2020 | $5.2M | -26.4% |
| FY2019 | $7.0M | -0.1% |
| FY2018 | $7.0M | +43.8% |
| FY2017 | $4.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice